Attorney General James Challenges Anticompetitive Conduct in the Generic Drug Industry

Posted to Applied Web NY on Wed, 06/10/2020 - 12:08

NEW YORK – New York Attorney General Letitia James, as part of a coalition of 51 attorneys general from around the nation, today filed an antitrust complaint in federal court alleging that key individual executives and manufacturers of dermatological, generic drugs engaged in a widespread conspiracy to artificially inflate and manipulate prices, reduce competition, and unreasonably restrain trade for generic drugs sold across the United States. The complaint alleges broad, coordinated, and systematic antitrust violations, price-fixing, market allocating, and the rigging of bids for more than 80 different topical, generic drugs. The complaint also shines a light on an overarching conspiracy across the industry that links those individual agreements together.